CD8A and neoplasm: TILs are effective in delaying tumor progression by directly killing tumoral cells (CD8+ cytotoxic T lymphocytes), or by facilitating their detection and destruction (T helper lymphocytes, types 1 and 2), and have been shown to be predictive of good outcomes in many cancers.25